Luteinizing hormone
- Generic Name
- Luteinizing hormone
- Brand Names
- Menopur
- Drug Type
- Biotech
- CAS Number
- 9002-67-9
- Unique Ingredient Identifier
- 8XA4VN1LH4
- Associated Conditions
- Female Infertility, Men Infertility
- Associated Therapies
- Ovarian Hyperstimulation
Ketoconazole Contributes to Cryptorchidism Outcome Via Modulating Macrophage Trem2
Not Applicable
Recruiting
- Conditions
- Cryptorchidism
- Interventions
- First Posted Date
- 2024-08-19
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Affiliated Hospital of Nantong University
- Target Recruit Count
- 10
- Registration Number
- NCT06560086
- Locations
- 🇨🇳
Affiliated hospital of nantong university, Nantong, Jiangsu, China
Progestin Priming Ovarian Stimulation (PPOS) Compared With Antagonist Protocol for Freeze-all Cycles
- First Posted Date
- 2019-08-12
- Last Posted Date
- 2022-06-15
- Lead Sponsor
- Ibn Sina Hospital
- Target Recruit Count
- 56
- Registration Number
- NCT04052607
- Locations
- 🇪🇬
IbnSina IVF Center, IbnSina Hospital, Sohag, Egypt
🇪🇬Banon Fertility Center, Assiut, Egypt
🇪🇬AlRahma Hospital, Sohag, Egypt
Hormonal Mechanisms of Sleep Restriction - Axis Study
Phase 1
Active, not recruiting
- Conditions
- Sleep Restriction
- Interventions
- Drug: Placebo oral capsuleDrug: Saline SolutionDrug: Saline Solution for Injection
- First Posted Date
- 2017-05-08
- Last Posted Date
- 2024-04-23
- Target Recruit Count
- 80
- Registration Number
- NCT03142893
- Locations
- 🇺🇸
Los Angeles Biomedical Research Institute, Torrance, California, United States
Pregnancy Rate by HCG Administration Versus Urinary LH Surge Method in Patients Undergoing IUI
- First Posted Date
- 2015-12-23
- Last Posted Date
- 2015-12-23
- Lead Sponsor
- Shiraz University of Medical Sciences
- Target Recruit Count
- 86
- Registration Number
- NCT02638285
- Locations
- 🇮🇷
Health Policy Research Center, Shiraz, Fars, Iran, Islamic Republic of
Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS
- First Posted Date
- 2014-07-25
- Last Posted Date
- 2020-11-24
- Lead Sponsor
- San Carlo Public Hospital, Potenza, Italy
- Target Recruit Count
- 16
- Registration Number
- NCT02200952
- Locations
- 🇮🇹
San Carlo Public Hospital, Potenza, Basilicata, Italy
🇮🇹San carlo Public Hospital, Potenza, Basilica, Italy
Endometrial Receptivity After GnRH Agonist Triggering
Phase 4
Completed
- Conditions
- Ovarian Hyperstimulation Syndrome
- Interventions
- First Posted Date
- 2011-12-29
- Last Posted Date
- 2016-10-26
- Lead Sponsor
- IVI Madrid
- Target Recruit Count
- 35
- Registration Number
- NCT01500863
- Locations
- 🇪🇸
Instituto Valenciano de Infertilidad, Madrid, Spain
Reproductive Hormonal Alterations in Obesity
Not Applicable
Completed
- Conditions
- Obesity
- Interventions
- First Posted Date
- 2011-10-24
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 62
- Registration Number
- NCT01457703
- Locations
- 🇺🇸
Clinical Translational Research Center, Aurora, Colorado, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath